In ABC‐DLBCL, TLR9 and B cell receptors together constitute tumor driver genes. TLR9 activates various cytokines including IL‐10, and has cross‐linking effects with multiple malignant signaling pathways [150]. This evidence concerns the gene TLR9 and neoplasm.